Evaluating the Efficacy and Safety of PT027 Compared with PT007 Administered As Needed in Participants 12 to < 18 Years of Age with Asthma

Trial Identifier: D6934C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT06307665
Start Date: May 2024
Primary Completion Date: October 2027
Study Completion Date: October 2027
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, FL Destin, FL, US, 32541
US, IN Indianapolis, IN, US, 46202
US, LA Lafayette, LA, US, 70508
US, MD White Marsh, MD, US, 21162
US, MI Detroit, MI, US, 48201
US, MN Mankato, MN, US, 56001
US, NJ Newark, NJ, US, 07103
US, NJ Ocean, NJ, US, 07712
US, NM Albuquerque, NM, US, 87106
US, NY Cortland, NY, US, 13045
US, NY Hawthorne, NY, US, 10532
US, NY New York, NY, US, 10032
US, NY Vestal, NY, US, 13850
US, NY Watertown, NY, US, 13601
US, OH Cincinnati, OH, US, 45229
US, OK Oklahoma City, OK, US, 73120
US, PA Pittsburgh, PA, US, 15241
US, SD Sioux Falls, SD, US, 57105
US, Texas Houston, Texas, US, 77065
US, TX Austin, TX, US, 78759
US, TX Beaumont, TX, US, 77701
US, TX Corsicana, TX, US, 75110
US, TX Dallas, TX, US, 75231
US, TX San Antonio, TX, US, 78229
US, WA Bellingham, WA, US, 98225